STUDY DESIGN OF INTRAVENOUS EFGARTIGIMOD IN JUVENILE GENERALIZED MYASTHENIA GRAVIS

被引：0
|
作者：
Kuntz, Nancy L. [1 ]
Bogatyreva, Anna [2 ]
Podhorna, Jana [2 ]
Steeland, Sophie [2 ]
Van Bragt, Tonke [2 ]
Van Hoorick, Benjamin [2 ]
Guglietta, Antonio [2 ]
Howard, James F., Jr. [3 ]
机构：
[1] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Div Neurol, Dept Pediat,Feinberg Sch Med, Chicago, IL USA
[2] argenx, Ghent, Belgium
[3] Univ N Carolina, Chapel Hill, NC USA
来源：
MUSCLE & NERVE | 2022年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S12 / S13
页数：2
相关论文
共 50 条
  • [21] Intravenous immunoglobulin therapy for generalized Myasthenia Gravis
    Wolfe, GI
    Barohn, RJ
    Foster, BM
    Jackson, CE
    Kissel, JT
    Day, JW
    Thorton, CA
    NEUROLOGY, 2000, 54 (07) : A137 - A137
  • [22] A Real-life experience with Eculizumab and Efgartigimod in generalized Myasthenia Gravis patients
    Sacca, F.
    Cuomo, N.
    Russo, C.
    Campanile, M.
    Puorro, G.
    Marsili, A.
    Pane, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 569 - 569
  • [23] A real world experience with Efgartigimod in generalized Myasthenia Gravis in a national reference center
    Antozzi, C.
    Frangiamore, R.
    Rinaldi, E.
    Vanoli, F.
    Andreetta, F.
    Ciusani, E.
    Bonanno, S.
    Maggi, L.
    Gallone, A.
    Pinna, A.
    Mantegazza, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 204 - 204
  • [24] Efgartigimod alfa-the importance of FcRn blockade in the treatment of generalized myasthenia gravis
    Bozovsky, Tomas
    Ehler, Edvard
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2023, 86 (03) : 214 - 217
  • [25] A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients
    Pane, Chiara
    Di Stefano, Vincenzo
    Cuomo, Nunzia
    Sarnataro, Alessio
    Vinciguerra, Claudia
    Bevilacqua, Liliana
    Brighina, Filippo
    Rini, Nicasio
    Puorro, Giorgia
    Marsili, Angela
    Garibaldi, Matteo
    Fionda, Laura
    Sacca, Francesco
    JOURNAL OF NEUROLOGY, 2024, 271 (09) : 6209 - 6219
  • [26] THE EFFECT OF OBESITY IN EFFICACY AND SAFETY IN THE ADAPT TRIAL OF EFGARTIGIMOD FOR GENERALIZED MYASTHENIA GRAVIS
    Pulley, Michael
    Pasnoor, Mamatha
    Gelinas, Deborah
    Brauer, Edward
    Kerstens, Rene
    Beydoun, Said
    Howard, James
    MUSCLE & NERVE, 2022, 66 : S105 - S105
  • [27] MINIMAL SYMPTOM EXPRESSION IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS FROM TREATMENT WITH EFGARTIGIMOD
    Howard, James
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Pasnoor, Mamatha
    Muppidi, Srikanth
    Peric, Stojan
    Murai, Hiroyuki
    Guglietta, Antonio
    Ulrichts, Peter
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    MUSCLE & NERVE, 2021, 64 : S3 - S4
  • [28] Additional Analyses of the Phase 2 Efgartigimod Study in Myasthenia Gravis
    Howard, James
    Bril, Vera
    Mantegazza, Renato
    Beydoun, Said
    De Rivera Garrido, Fancisco Javier
    Piehl, Fredrik
    Rottoli, Maria Rosa
    Van Damme, Philip
    Vu, Tuan
    Ulrichts, Peter
    Guglietta, Antonio
    Beauchamp, Jon
    de Haard, Hans
    Verschuuren, Jan
    NEUROLOGY, 2020, 94 (15)
  • [29] Efficacy, Safety, and Tolerability of Efgartigimod in Patients With Generalized Myasthenia Gravis: Analysis of the Phase 3 ADAPT Study
    Howard, James
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Peric, Stojan
    Murai, Hiroyuki
    Guglietta, Antonio
    Ulrichts, Peter
    Vangeneugden, Tony
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    NEUROLOGY, 2021, 96 (15)
  • [30] Efgartigimod is safe and effective in myasthenia gravis with sepsis
    Thakre, Mona
    Hussein, Mohamed
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
12345